Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-06-21
2011-06-21
Moore, Susanna (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S262000
Reexamination Certificate
active
07964607
ABSTRACT:
The invention provides PDE9-inhibiting compounds of Formula (I),and pharmaceutically acceptable salts thereof, wherein R, R1, R2and R3are as defined herein. Pharmaceutical compositions containing the compounds of Formula I, and uses thereof in treating neurodegenerative and cognitive disorders, such as Alzheimer's disease and schizophrenia, are also provided.
REFERENCES:
patent: 2003/0139427 (2003-07-01), Castelhano et al.
patent: 2004/0176361 (2004-09-01), Fujio et al.
patent: 2004/0259870 (2004-12-01), Feng et al.
patent: 1460077 (2004-09-01), None
patent: 02085904 (2002-10-01), None
patent: 2004037176 (2004-05-01), None
Wunder et al., Mol. Pharmacol., vol. 28, No. 6, (2005), pp. 1776-1781.
van der Staay et al., Neuropharmacology, vol. 55 (2008), pp. 908-918.
Proulx-Lafrance Caroline
Verhoest Patrick Robert
Herman Michael
Kispert Jennifer A.
Moore Susanna
Pfizer Inc.
LandOfFree
Pyrazolo[3,4-d]pyrimidine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazolo[3,4-d]pyrimidine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolo[3,4-d]pyrimidine compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2675757